Peter Steven St Insider Trading $ALT Altimmune, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter Steven St.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter Steven St. Peter Steven St is Director in PHARMATHENE, INC ($PIP) and Director in Omrix Biopharmaceuticals, Inc. ($OMRI) and PRESIDENT AND CEO in ARATANA THERAPEUTICS, INC. ($PETX).

Peter Steven St in Altimmune, Inc.

Trading Symbol: ALT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Steven St: Director
Holdings: 145,004 shares
Current Value: $198,655
Latest Transaction: Jan 05 2017
$ALT Market Capitalization: $76.74M
$ALT Previous Close: $1.37

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Peter Steven St in Altimmune, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALT, PETX, OMRI

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM2.2020,00044,0000
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM3.1120,00062,2000
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM2.4720,00049,4000
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM2.5910,00025,9000
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM2.2020,00044,000205,004185 K to 205 K (+10.81 %)
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM3.1120,00062,200185,004165 K to 185 K (+12.12 %)
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM2.4720,00049,400165,004145 K to 165 K (+13.79 %)
Jan 05 2017PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM2.5910,00025,900145,004135 K to 145 K (+7.41 %)
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM1.6920,00033,8000
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM1.8110,00418,1070
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM1.5120,00030,2000
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM1.6420,00032,8000
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM1.4520,00029,0000
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseM1.6020,00032,0000
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM1.6920,00033,800135,004115 K to 135 K (+17.39 %)
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM1.8110,00418,107115,004105 K to 115 K (+9.53 %)
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM1.5120,00030,200105,00085 K to 105 K (+23.53 %)
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM1.6420,00032,80085,00065 K to 85 K (+30.77 %)
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM1.4520,00029,00065,00045 K to 65 K (+44.44 %)
Sep 20 2016PIPPHARMATHENE, INCSt Peter StevenDirectorBuyM1.6020,00032,00045,00025 K to 45 K (+80.00 %)
Jun 03 2016PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseA2.2020,00044,00020,000
Aug 04 2015PIPPHARMATHENE, INCSt Peter StevenDirectorOption ExerciseA1.6920,00033,80020,000
Mar 23 2015PIPPHARMATHENE, INCSt Peter StevenDirectorBuyP1.6525,00041,21325,0000 to 25 K

Page:   1